FDA Inspection 1069147 — FXM Clinical Research Miramar LLC
The FDA completed an inspection of FXM Clinical Research Miramar LLC on Sep 10, 2018 in Miramar, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Sep 10, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Miramar, FL (United States)
Additional Details
Clinical BA/BE